RPRX logo

Royalty Pharma plc (RPRX) Cash from investing

annual CFI:

-$2.70B-$592.43M(-28.15%)
December 31, 2024

Summary

  • As of today (September 14, 2025), RPRX annual cash flow from investing activities is -$2.70 billion, with the most recent change of -$592.43 million (-28.15%) on December 31, 2024.
  • During the last 3 years, RPRX annual CFI has fallen by -$870.06 million (-47.63%).
  • RPRX annual CFI is now -988.74% below its all-time high of $303.42 million, reached on December 31, 2018.

Performance

RPRX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

quarterly CFI:

-$311.98M-$815.90M(-161.91%)
June 30, 2025

Summary

  • As of today (September 14, 2025), RPRX quarterly cash flow from investing activities is -$311.98 million, with the most recent change of -$815.90 million (-161.91%) on June 30, 2025.
  • Over the past year, RPRX quarterly CFI has increased by +$581.19 million (+65.07%).
  • RPRX quarterly CFI is now -161.91% below its all-time high of $503.92 million, reached on March 31, 2025.

Performance

RPRX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

TTM CFI:

-$1.51B+$581.19M(+27.84%)
June 30, 2025

Summary

  • As of today (September 14, 2025), RPRX TTM cash flow from investing activities is -$1.51 billion, with the most recent change of +$581.19 million (+27.84%) on June 30, 2025.
  • Over the past year, RPRX TTM CFI has increased by +$924.30 million (+38.03%).
  • RPRX TTM CFI is now -128.97% below its all-time high of -$657.88 million, reached on September 30, 2023.

Performance

RPRX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

RPRX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.1%+65.1%+38.0%
3 y3 years-47.6%-933.8%-6.4%
5 y5 years-27.4%-27.4%+10.6%

RPRX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-163.8%at low-161.9%+78.1%-129.0%+52.5%
5 y5-year-163.8%+0.4%-161.9%+78.1%-129.0%+52.5%
alltimeall time-988.7%+0.4%-161.9%+78.1%-129.0%+52.5%

RPRX Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$311.98M(-161.9%)
-$1.51B(-27.8%)
Mar 2025
-
$503.92M(-199.7%)
-$2.09B(-22.1%)
Dec 2024
-$2.70B(+28.2%)
-$505.59M(-57.6%)
-$2.68B(-15.6%)
Sep 2024
-
-$1.19B(+33.5%)
-$3.17B(+30.5%)
Jun 2024
-
-$893.18M(+930.8%)
-$2.43B(+51.8%)
Mar 2024
-
-$86.65M(-91.3%)
-$1.60B(-22.8%)
Dec 2023
-$2.10B(+105.8%)
-$1.00B(+121.9%)
-$2.07B(+215.1%)
Sep 2023
-
-$450.66M(+610.4%)
-$657.88M(-59.7%)
Jun 2023
-
-$63.43M(-88.6%)
-$1.63B(+2.1%)
Mar 2023
-
-$558.53M(-234.7%)
-$1.60B(+55.3%)
Dec 2022
-$1.02B(-44.0%)
$414.74M(-129.1%)
-$1.03B(-48.4%)
Sep 2022
-
-$1.43B(+4622.5%)
-$2.00B(+40.9%)
Jun 2022
-
-$30.18M(-370.3%)
-$1.42B(+12.4%)
Mar 2022
-
$11.16M(-102.0%)
-$1.26B(-32.6%)
Dec 2021
-$1.83B
-$551.65M(-34.8%)
-$1.87B(-13.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$845.50M(-770.1%)
-$2.15B(-3.4%)
Jun 2021
-
$126.17M(-121.1%)
-$2.23B(-14.3%)
Mar 2021
-
-$599.30M(-28.0%)
-$2.60B(-5.9%)
Dec 2020
-$2.71B(+27.9%)
-$832.40M(-9.5%)
-$2.76B(+38.7%)
Sep 2020
-
-$920.20M(+275.6%)
-$1.99B(+18.1%)
Jun 2020
-
-$244.97M(-67.8%)
-$1.68B(+5.4%)
Mar 2020
-
-$761.75M(+1112.7%)
-$1.60B(-25.8%)
Dec 2019
-$2.12B(-797.4%)
-$62.82M(-89.8%)
-$2.15B(+3.0%)
Sep 2019
-
-$615.27M(+288.5%)
-$2.09B(+41.7%)
Jun 2019
-
-$158.37M(-88.0%)
-$1.48B(+12.0%)
Mar 2019
-
-$1.32B
-$1.32B
Dec 2018
$303.42M(-119.1%)
-
-
Dec 2017
-$1.59B(+162.0%)
-
-
Dec 2016
-$605.93M(-1042.5%)
-
-
Dec 2015
$64.29M
-
-

FAQ

  • What is Royalty Pharma plc annual cash flow from investing activities?
  • What is the all time high annual CFI for Royalty Pharma plc?
  • What is Royalty Pharma plc annual CFI year-on-year change?
  • What is Royalty Pharma plc quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly CFI year-on-year change?
  • What is Royalty Pharma plc TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM CFI year-on-year change?

What is Royalty Pharma plc annual cash flow from investing activities?

The current annual CFI of RPRX is -$2.70B

What is the all time high annual CFI for Royalty Pharma plc?

Royalty Pharma plc all-time high annual cash flow from investing activities is $303.42M

What is Royalty Pharma plc annual CFI year-on-year change?

Over the past year, RPRX annual cash flow from investing activities has changed by -$592.43M (-28.15%)

What is Royalty Pharma plc quarterly cash flow from investing activities?

The current quarterly CFI of RPRX is -$311.98M

What is the all time high quarterly CFI for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly cash flow from investing activities is $503.92M

What is Royalty Pharma plc quarterly CFI year-on-year change?

Over the past year, RPRX quarterly cash flow from investing activities has changed by +$581.19M (+65.07%)

What is Royalty Pharma plc TTM cash flow from investing activities?

The current TTM CFI of RPRX is -$1.51B

What is the all time high TTM CFI for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM cash flow from investing activities is -$657.88M

What is Royalty Pharma plc TTM CFI year-on-year change?

Over the past year, RPRX TTM cash flow from investing activities has changed by +$924.30M (+38.03%)
On this page